Showing results (1121-1130 of 1,506) with videos related to

Sort By:
Pageof 151
BMC Pediatrics|November 16, 2004
Healthcare professionals' perceptions of pain in infants at risk for neurological impairmentLynn M Breau, Patrick J McGrath, Bonnie Stevens, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2018
Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputumMichael M Tunney, Joanna E Payne, Stephanie J McGrath, et al.
Journal of Medical Microbiology|June 13, 2017
Evidence of persistence of Prevotella spp. in the cystic fibrosis lungD F Gilpin, K A Nixon, M Bull, et al.
Plos One|April 5, 2024
Using a data-driven approach to define post-COVID conditions in US electronic health record dataKathleen M Andersen, Farid L Khan, Peter W Park, et al.
Journal of Neurovirology|April 25, 2012
Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in KenyaChristine J McGrath, Julia Njoroge, Grace C John-Stewart, et al.
Archives of General Psychiatry|July 1, 1984
Phenelzine v imipramine in atypical depression. A preliminary reportM R Liebowitz, F M Quitkin, J W Stewart, et al.
The British Journal of Psychiatry. Supplement|September 1, 1993
Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placeboF M Quitkin, J W Stewart, P J McGrath, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 15, 1999
OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neuronsK M Campbell, L de Lecea, D M Severynse, et al.
The American Journal of Psychiatry|November 2, 2002
Are there differences between women's and men's antidepressant responses?Frederic M Quitkin, Jonathan W Stewart, Patrick J McGrath, et al.
Annals of General Psychiatry|March 2, 2010
Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetineHuaiyu Yang, Lara Sinicropi-Yao, Sarah Chuzi, et al.
Pageof 151